Vibrant Therapeutics
- Biotech or pharma, therapeutic R&D
Vibrant Therapeutics develops Best-in-Class Masked T Cell Engager (mTCE) prodrugs for Oncology, autoimmune disease, inflammation and other indications, using its LogicBee prodrug platform. We are looking for Series B funding to enter in Clinical Trials this year with our lead assets in solid tumors; and actively pursuing out-licensing, co-developing and partnering opportunities for other First-in-Class and Best-in-Class assets of our oncology, autoimmune and inflammation pipeline
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}